List of insiders holdings for MISONIX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | 1315 Capital Management LLC 1315 Capital L.P. 10% Owner | 2021-02-05 16:49:27 | 0 1,695,969 | 1,695,969 | Form 4 |
| 2 | MCMANUS MICHAEL A JR President and CEO | 2016-07-01 13:28:57 | 426,017 0 | 426,017 | Form 4 |
| 3 | ZAREMBA RICHARD A Sr. VP - Finance | 2017-06-06 10:59:18 | 138,523 0 | 138,523 | Form 4 |
| 4 | ALLIGER HOWARD Director Emeritus | 2015-06-17 06:00:49 | 70,400 0 | 70,400 | Form 4 |
| 5 | Napoli Frank VP, Operations | 2014-06-12 10:30:02 | 41,500 0 | 41,500 | Form 4 |
| 6 | Manna Ronald VP, Quality & Reg. Aff. | 2015-02-24 15:40:08 | 36,475 0 | 36,475 | Form 4 |
| 7 | Ryan Michael C SVP, Medical Division | 2012-09-13 13:27:24 | 35,000 0 | 35,000 | Form 4 |
| 8 | Klugewicz Sharon W Chief Operating Officer | 2021-07-02 16:30:37 | 15,000 0 | 15,000 | Form 4 |
| 9 | Waggoner Jonathan Jay SVP, Wound Sales | 2021-07-02 16:31:00 | 15,000 0 | 15,000 | Form 4 |
| 10 | McBrayer Patrick A Director | 2018-11-16 10:51:14 | 15,000 0 | 15,000 | Form 4 |
| 11 | MINETTI T GUY Director | 2016-02-08 14:30:59 | 15,000 0 | 15,000 | Form 4 |
| 12 | Miner Charles Director | 2018-11-16 10:46:18 | 15,000 0 | 15,000 | Form 4 |
| 13 | GILDEA JOHN Director | 2017-08-18 16:06:05 | 15,000 0 | 15,000 | Form 4 |
| 14 | Berger Bernhard VP-Industrial/Scientific Prod. | 2005-03-04 10:12:37 | 13,334 0 | 13,334 | Form 4 |
| 15 | VOIC DAN VP, R&D and Engineering | 2018-07-26 16:06:00 | 12,000 0 | 12,000 | Form 4 |
| 16 | Constantine W Paul SVP, Sales & New Prod. | 2006-10-24 10:31:46 | 10,000 0 | 10,000 | Form 4 |
| 17 | Salerno John Joseph VP, Quality & Regulatory | 2018-07-26 16:05:21 | 10,000 0 | 10,000 | Form 4 |
| 18 | Staley Allan Richard President | 2020-07-02 13:36:23 | 8,465 0 | 8,465 | Form 4 |
| 19 | Consilvio Michael L VP-Marketing | 2016-12-08 19:51:37 | 8,000 0 | 8,000 | Form 4 |
| 20 | ONEILL THOMAS F Director | 2015-02-26 08:33:40 | 6,300 0 | 6,300 | Form 4 |
| 21 | Brennan Joseph J VP, Operations | 2019-02-12 16:30:25 | 5,292 0 | 5,292 | Form 4 |
| 22 | Staub Linwood A. Sr. VP Wound | 2020-07-02 13:40:21 | 4,998 0 | 4,998 | Form 4 |
| 23 | Coviello Kenneth V.P - Medical Devices | 2005-09-28 15:08:53 | 4,000 0 | 4,000 | Form 4 |
| 24 | Watanabe Gwendolyn A Director | 2020-07-02 13:37:24 | 3,060 0 | 3,060 | Form 4 |
| 25 | Wright Christopher H VP - US Sales | 2018-11-29 12:42:04 | 0 2,000 | 2,000 | Form 4 |
| 26 | SVLSF VI LLC SV Life Sciences Fund VI L.P. SV Life Sciences Fund VI (GP) L.P. SV Life Sciences Fund VI Strategic Partners L.P. 10% Owner | 2021-02-16 16:01:08 | 0 0 | 0 | Form 13G |
| 27 | GELMAN GARY 10% Owner | 2010-03-19 09:13:07 | 0 0 | 0 | Form 13D |
| 28 | Beyer Pat Director | 2021-12-08 16:42:27 | 0 0 | 0 | Form 4 |
| 29 | Dwyer Joseph P Chief Financial Officer | 2021-12-08 16:45:12 | 0 0 | 0 | Form 4 |
| 30 | LAVIOLETTE PAUL A Director | 2021-12-08 16:47:41 | 0 0 | 0 | Form 4 |
| 31 | Ludecker Robert S SVP, Global Sales - Marketing | 2021-12-08 16:50:53 | 0 0 | 0 | Form 4 |
| 32 | PATTON THOMAS M Director | 2021-12-08 16:53:29 | 0 0 | 0 | Form 4 |
| 33 | Vizirgianakis Stavros G. President and CEO | 2021-12-08 16:56:38 | 0 0 | 0 | Form 4 |
| 34 | Koby Michael Director | 2021-12-08 17:01:08 | 0 0 | 0 | Form 4 |